With an aging population susceptible to stroke, Parkinson?s disease and other neurological conditions, and military personnel returning from Iraq and Afghanistan with serious limb injuries, the need for strategies that treat complex neurological impairments has never been greater.
Charles P. O?Brien, M.D., Ph.D., vice chair, Department of Psychiatry, University of Pennsylvania Health System, and research director, MIRECC, Philadelphia VA Medical Center, will present “Promising Approaches in the Treatment of Drug Addiction” at the 2007 American Association for the Advancement of Science (AAAS) Annual Meeting in San Francisco.
Men who have had a vasectomy may face an increased risk of developing a rare type of dementia, Northwestern University researchers discovered.
A completely new approach to the study of Alzheimer?s disease, initiated by a professor at the University of California, Santa Barbara, may solve a critical piece in the puzzle of the disease. This tragic neurological illness progressively erases memory in its millions of victims. The key to the new approach is understanding the way certain proteins in the brain fold, or rather ?misfold.?
For those who pumped up the volume one too many times, UC Irvine researchers may have found a treatment for the hearing damage loud music can cause.
Breastfed kids climb higher up the social ladder than bottle-fed children, reveals a large, long term study, published ahead of print in the Archives of Disease in Childhood.
Children snacking in big groups eat almost a third more than when snacking with a couple of mates, reveals research published ahead of print in the Archives of Disease in Childhood.
There is no convincing evidence that taking omega-3 fatty acids on their own can alleviate depression, says Drug and Therapeutics Bulletin (DTB).
NIDA unveils its first consumer publication to explain the science of addiction. Booklet’s release timed to complement collaborative documentary on addiction to air on HBO.
People who have multiple sclerosis (MS) for 10 years and have few of the disabling symptoms of the disease are often told they have “benign MS” and that their symptoms will likely not ever occur to the same extent as other people with MS.